1
|
Gao Y, Wu Y, Xu D, Bao L, Ding X, Lv L, Ma C, Bian T, Han S. Chlamydia psittaci pneumonia in Wuxi, China: retrospective analysis of 55 cases and predictors of severe disease. Front Med (Lausanne) 2023; 10:1150746. [PMID: 37671399 PMCID: PMC10475936 DOI: 10.3389/fmed.2023.1150746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2023] [Accepted: 08/07/2023] [Indexed: 09/07/2023] Open
Abstract
Purpose More and more patients with community-acquired pneumonia have been detected with Chlamydia psittaci (C. psittaci) infected using metagenomic next-generation sequencing (mNGS). Previously, this was unheard of, and several patients presented with severe pneumonia and even required ECMO. We aimed to clarify the clinical characteristics of C. psittaci pneumonia and find out if there are any possible predictors of severe C. psittaci pneumonia. Methods In this retrospective study, we included all confirmed cases of C. psittaci pneumonia in Wuxi. Epidemiological, clinical, and radiological features, as well as laboratory data, were collected and analyzed. Results We enrolled 55 patients with C. psittaci pneumonia, with 30 (54.5%) having a history of exposure to birds or their internal organs. 50 (90.9%) patients were diagnosed by mNGS. Patients with C. psittaci pneumonia had many complications, among which, that deserve sufficient attention from clinicians were vascular embolic events (3, 5.5%). High fever was the most common clinical manifestation (41, 74.5%). The majority of patients had a significant increase in neutrophils ratio, neutrophils to lymphocytes ratio (NLR), rapid c-reactive protein, creatine kinase (CK), and lactate dehydrogenase (LDH), as well as a decrease in lymphocytes ratio, albumin, serum sodium, serum potassium, and serum phosphorus. Chest computed tomography scans revealed unilateral pneumonia (70.9%), consolidation (87.3%), air bronchogram (76.4%), and ground-glass opacity (69.1%). The neutrophil ratio, NLR, LDH, and CK were all factors that could identify severe pneumonia. Both AUCs exceeded 0.8; the respective 95% CIs were 0.715-0.944, 0.710-0.963, 0.677-0.937, and 0.718-0.950; all p < 0.05 (0.01, 0.001, 0.007, 0.007 respectively). The ORs were 10.057, 9.750, 10.057, and 9.667, respectively; the 95% CIs were 2.643-38.276, 2.339-40.649, and 2.643-38.276, respectively; all p-values were less than 0.05 (0.001, 0.002, 0.001, 0.001 respectively). Conclusion C. psittaci pneumonia is a very complex disease that changes all the time. Some patients showed severe pneumonia. Patients will have a poor prognosis if they are not treated promptly and effectively. We discovered that many clinical indicators were typical. Meanwhile, significant increases in neutrophil ratio, NLR, LDH, and CK predicted severe pneumonia. Timely detection of mNGS provided substantial help for clinical diagnosis and early treatment.
Collapse
Affiliation(s)
- Ying Gao
- Department of Respiratory and Critical Care Medicine, Wuxi No.2 People’s Hospital (Jiangnan University Medical Center), Wuxi, China
| | - Yan Wu
- Department of Respiratory and Critical Care Medicine, The Wuxi People’s Hospital, Wuxi, China
| | - Dan Xu
- Department of Respiratory and Critical Care Medicine, The Xishan People’s Hospital of Wuxi City, Wuxi, China
| | - Liang Bao
- Department of Respiratory and Critical Care Medicine, Wuxi No.2 People’s Hospital (Jiangnan University Medical Center), Wuxi, China
| | - Xiao Ding
- Department of Respiratory and Critical Care Medicine, The Wuxi Fifth People’s Hospital (Jiangnan University Medical Center), Wuxi, China
| | - Lei Lv
- Department of Respiratory and Critical Care Medicine, Wuxi No.2 People’s Hospital (Jiangnan University Medical Center), Wuxi, China
| | - Chenhui Ma
- Department of Respiratory and Critical Care Medicine, Wuxi No.2 People’s Hospital (Jiangnan University Medical Center), Wuxi, China
| | - Tao Bian
- Department of Respiratory and Critical Care Medicine, The Wuxi People’s Hospital, Wuxi, China
| | - Shuguang Han
- Department of Respiratory and Critical Care Medicine, Wuxi No.2 People’s Hospital (Jiangnan University Medical Center), Wuxi, China
| |
Collapse
|
2
|
Luetkemeyer AF, Donnell D, Dombrowski JC, Cohen S, Grabow C, Brown CE, Malinski C, Perkins R, Nasser M, Lopez C, Vittinghoff E, Buchbinder SP, Scott H, Charlebois ED, Havlir DV, Soge OO, Celum C. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. N Engl J Med 2023; 388:1296-1306. [PMID: 37018493 PMCID: PMC10140182 DOI: 10.1056/nejmoa2211934] [Citation(s) in RCA: 101] [Impact Index Per Article: 101.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/07/2023]
Abstract
BACKGROUND Interventions to reduce sexually transmitted infections (STIs) among men who have sex with men (MSM) are needed. METHODS We conducted an open-label, randomized study involving MSM and transgender women who were taking preexposure prophylaxis (PrEP) against human immunodeficiency virus (HIV) infection (PrEP cohort) or living with HIV infection (persons living with HIV infection [PLWH] cohort) and who had had Neisseria gonorrhoeae (gonorrhea), Chlamydia trachomatis (chlamydia), or syphilis in the past year. Participants were randomly assigned in a 2:1 ratio to take 200 mg of doxycycline within 72 hours after condomless sex (doxycycline postexposure prophylaxis) or receive standard care without doxycycline. STI testing was performed quarterly. The primary end point was the incidence of at least one STI per follow-up quarter. RESULTS Of 501 participants (327 in the PrEP cohort and 174 in the PLWH cohort), 67% were White, 7% Black, 11% Asian or Pacific Islander, and 30% Hispanic or Latino. In the PrEP cohort, an STI was diagnosed in 61 of 570 quarterly visits (10.7%) in the doxycycline group and 82 of 257 quarterly visits (31.9%) in the standard-care group, for an absolute difference of -21.2 percentage points and a relative risk of 0.34 (95% confidence interval [CI], 0.24 to 0.46; P<0.001). In the PLWH cohort, an STI was diagnosed in 36 of 305 quarterly visits (11.8%) in the doxycycline group and 39 of 128 quarterly visits (30.5%) in the standard-care group, for an absolute difference of -18.7 percentage points and a relative risk of 0.38 (95% CI, 0.24 to 0.60; P<0.001). The incidences of the three evaluated STIs were lower with doxycycline than with standard care; in the PrEP cohort, the relative risks were 0.45 (95% CI, 0.32 to 0.65) for gonorrhea, 0.12 (95% CI, 0.05 to 0.25) for chlamydia, and 0.13 (95% CI, 0.03 to 0.59) for syphilis, and in the PLWH cohort, the relative risks were 0.43 (95% CI, 0.26 to 0.71), 0.26 (95% CI, 0.12 to 0.57), and 0.23 (95% CI, 0.04 to 1.29), respectively. Five grade 3 adverse events and no serious adverse events were attributed to doxycycline. Of the participants with gonorrhea culture available, tetracycline-resistant gonorrhea occurred in 5 of 13 in the doxycycline groups and 2 of 16 in the standard-care groups. CONCLUSIONS The combined incidence of gonorrhea, chlamydia, and syphilis was lower by two thirds with doxycycline postexposure prophylaxis than with standard care, a finding that supports its use among MSM with recent bacterial STIs. (Funded by the National Institutes of Health; DoxyPEP ClinicalTrials.gov number, NCT03980223.).
Collapse
Affiliation(s)
- Anne F Luetkemeyer
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Deborah Donnell
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Julia C Dombrowski
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Stephanie Cohen
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Cole Grabow
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Clare E Brown
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Cheryl Malinski
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Rodney Perkins
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Melody Nasser
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Carolina Lopez
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Eric Vittinghoff
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Susan P Buchbinder
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Hyman Scott
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Edwin D Charlebois
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Diane V Havlir
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Olusegun O Soge
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| | - Connie Celum
- From Zuckerberg San Francisco General Hospital and Trauma Center (A.F.L., C.L., D.V.H.), and the Departments of Medicine (A.F.L., S.C., C.L., E.V., D.V.H.) and Epidemiology and Biostatistics (E.D.C), University of California, San Francisco, and San Francisco Department of Public Health, Population Health Division (S.C., M.N., S.P.B., H.S.) - both in San Francisco; and Fred Hutchinson Cancer Center (D.D.), the Departments of Medicine (J.C.D., O.O.S., C.C.), Global Health (C.G., C.E.B., R.P., O.O.S., C.C.), and Epidemiology (C.C.), and the School of Nursing (R.P.), University of Washington, and Public Health-Seattle and King County (J.C.D., C.M.) - all in Seattle
| |
Collapse
|
3
|
Lu B, Qiao Q, Park ER, Wang Y, Gilleran JA, Pan M, Pilch DS, Wu X, Roberge JY, Fan H. Acylpyrazoline-Based Third-Generation Selective Antichlamydial Compounds with Enhanced Potency. ACS OMEGA 2023; 8:6597-6607. [PMID: 36844602 PMCID: PMC9947980 DOI: 10.1021/acsomega.2c06992] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/01/2022] [Accepted: 01/30/2023] [Indexed: 06/18/2023]
Abstract
Chlamydiae are obligate intracellular Gram-negative bacteria and widespread pathogens in humans and animals. Broad-spectrum antibiotics are currently used to treat chlamydial infections. However, broad-spectrum drugs also kill beneficial bacteria. Recently, two generations of benzal acylhydrazones have been shown to selectively inhibit chlamydiae without toxicity to human cells and lactobacilli, which are dominating, beneficial bacteria in the vagina of reproductive-age women. Here, we report the identification of two acylpyrazoline-based third-generation selective antichlamydials (SACs). With minimal inhibitory concentrations (MIC) and minimal bactericidal concentrations (MBC) of 10-25 μM against Chlamydia trachomatis and Chlamydia muridarum, these new antichlamydials are 2- to 5-fold more potent over the benzal acylhydrazone-based second-generation selective antichlamydial lead SF3. Both acylpyrazoline-based SACs are well tolerated by Lactobacillus, Escherichia coli, Klebsiella, and Salmonella as well as host cells. These third-generation selective antichlamydials merit further evaluation for therapeutic application.
Collapse
Affiliation(s)
- Bin Lu
- Department
of Parasitology, Central South University
Xiangya Medical School, Changsha, Hunan 410013, China
- Department
of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States
| | - Qi Qiao
- Molecular
Design and Synthesis Core, RUBRIC, Office for Research, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States
| | - Elizabeth R. Park
- Molecular
Design and Synthesis Core, RUBRIC, Office for Research, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States
- Department
of Chemistry and Chemical Biology, Rutgers,
The State University of New Jersey, Piscataway, New Jersey 08854, United States
| | - Yuxuan Wang
- Department
of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States
| | - John A. Gilleran
- Molecular
Design and Synthesis Core, RUBRIC, Office for Research, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States
| | - Matthew Pan
- Department
of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States
| | - Daniel S. Pilch
- Department
of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States
| | - Xiang Wu
- Department
of Parasitology, Central South University
Xiangya Medical School, Changsha, Hunan 410013, China
| | - Jacques Y. Roberge
- Molecular
Design and Synthesis Core, RUBRIC, Office for Research, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States
| | - Huizhou Fan
- Department
of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States
| |
Collapse
|
4
|
Yang M, Yang DH, Yang H, Ding SZ, Liu CH, Yin HM, Liu D, Chen P, Luo H. Clinical Characteristics of Chlamydia psittaci Pneumonia Infection in Central South China. Infect Dis Ther 2022; 11:1631-1647. [PMID: 35723864 PMCID: PMC9207437 DOI: 10.1007/s40121-022-00662-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2022] [Accepted: 05/23/2022] [Indexed: 11/23/2022] Open
Abstract
Introduction Chlamydia psittaci pneumonia has been a global public health hotspot in recent years. Although some scattered cases of C. psittaci pneumonia have been reported, there is a lack of large case studies worldwide. Methods In this multicenter, observational study, we recruited all consecutive patients with confirmed C. psittaci pneumonia from October 4, 2018, to October 23, 2020, in nine tertiary general hospitals in Central-South China. Epidemiologic and clinical data from patients’ electronic medical records were collected and analyzed. Results One hundred and sixteen patients with C. psittaci pneumonia were included in the study. The mean age was 59.7 years. Fever (96.6%) and cough (65.5%) were the most common clinical symptoms. Most patients presented with an increase in the proportion of neutrophils, neutrophil to lymphocyte ratio, LDH, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) and a significant decrease in lymphocytes. The main CT lung findings were consolidation (81%) and pleural effusion (35.3%), and bilateral lung consolidation was mainly found in severe patients. Chlamydia psittaci DNA was detected in BALF (bronchoalveolar lavage fluid) or blood samples by metagenomic next-generation sequencing (mNGS) in all patients. Use of quinolone was associated with shorter length of hospital stay and fever duration after antibiotic use. Multivariate logistic regression analysis indicated that respiratory support was associated with both severe pneumonia and in-hospital death. Conclusions The clinical phenotype of C. psittaci pneumonia is complex and variable. mNGS is helpful in the diagnosis and treatment of C. psittaci pneumonia, and early treatment with quinolone may benefit patients. Supplementary Information The online version contains supplementary material available at 10.1007/s40121-022-00662-4.
Collapse
Affiliation(s)
- Min Yang
- Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China
- Research Unit of Respiratory Disease, Central South University, Changsha, 410011, Hunan, China
- Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, 410011, Hunan, China
| | - Dan-Hui Yang
- Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China
- Research Unit of Respiratory Disease, Central South University, Changsha, 410011, Hunan, China
- Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, 410011, Hunan, China
| | - Huan Yang
- Department of Respiratory Medicine, Hunan Provincial People's Hospital (the First Affiliated Hospital of Normal University), Changsha, 410011, Hunan, China
| | - Shui-Zi Ding
- Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China
- Research Unit of Respiratory Disease, Central South University, Changsha, 410011, Hunan, China
- Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, 410011, Hunan, China
| | - Cai-Hong Liu
- Department of Respiratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China
| | - Hui-Ming Yin
- Department of Respiratory Medicine, The First Affiliated Hospital of Hunan Medical College (Huaihua Third People's Hospital), Huaihua, 418001, Hunan, China
| | - Dan Liu
- Department of Respiratory Medicine, Changsha Hospital of Traditional Chinese Medicine (Changsha Eighth Hospital), Changsha, 410100, China
| | - Ping Chen
- Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.
- Research Unit of Respiratory Disease, Central South University, Changsha, 410011, Hunan, China.
- Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, 410011, Hunan, China.
| | - Hong Luo
- Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.
- Research Unit of Respiratory Disease, Central South University, Changsha, 410011, Hunan, China.
- Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, 410011, Hunan, China.
| |
Collapse
|
5
|
Marti H, Jelocnik M. Animal Chlamydiae: A Concern for Human and Veterinary Medicine. Pathogens 2022; 11:pathogens11030364. [PMID: 35335688 PMCID: PMC8951289 DOI: 10.3390/pathogens11030364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2022] [Accepted: 03/14/2022] [Indexed: 11/28/2022] Open
Affiliation(s)
- Hanna Marti
- Institute of Veterinary Pathology, Vetsuisse-Faculty University of Zurich, 8057 Zurich, Switzerland
- Correspondence: (H.M.); (M.J.)
| | - Martina Jelocnik
- Centre for Bioinnovation, University of the Sunshine Coast, Sippy Downs 4556, Australia
- Correspondence: (H.M.); (M.J.)
| |
Collapse
|
6
|
Ravichandran K, Anbazhagan S, Karthik K, Angappan M, Dhayananth B. A comprehensive review on avian chlamydiosis: a neglected zoonotic disease. Trop Anim Health Prod 2021; 53:414. [PMID: 34312716 PMCID: PMC8313243 DOI: 10.1007/s11250-021-02859-0] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2020] [Accepted: 07/09/2021] [Indexed: 01/12/2023]
Abstract
Avian chlamydiosis is one of the important neglected diseases with critical zoonotic potential. Chlamydia psittaci, the causative agent, affects most categories of birds, livestock, companion animals, and humans. It has many obscured characters and epidemiological dimensions, which makes it unique among other bacterial agents. Recent reports on transmission from equine to humans alarmed the public health authorities, and it necessitates the importance of routine screening of this infectious disease. High prevalence of spill-over infection in equines was associated with reproductive losses. Newer avian chlamydial species are being reported in the recent years. It is a potential biological warfare agent and the disease is an occupational hazard mainly to custom officers handling exotic birds. Prevalence of the disease in wild birds, pet birds, and poultry causes economic losses to the poultry industry and the pet bird trade. Interestingly, there are speculations on the ‘legal’ and ‘illegal’ bird trade that may be the global source of some of the most virulent strains of this pathogen. The mortality rate generally ranges from 5 to 40% in untreated cases, but it can sometimes be higher in co-infection. The intracellular lifestyle of this pathogen makes the diagnosis more complicated and there is also lack of accurate diagnostics. Resistance to antibiotics is reported only in some pathogens of the Chlamydiaceae family, but routine screening may assess the actual situation in all pathogens. Due to the diverse nature of the pathogen, the organism necessitates the One Health partnerships to have complete understanding. The present review focuses on the zoonotic aspects of avian chlamydiosis with its new insights into the pathogenesis, transmission, treatment, prevention, and control strategies. The review also briefs on the basic understandings and complex epidemiology of avian chlamydiosis, highlighting the need for research on emerging one health perspectives.
Collapse
Affiliation(s)
- Karthikeyan Ravichandran
- Division of Public Health and Epidemiology, ICAR-Indian Veterinary Research Institute, Izatnagar, India.
| | - Subbaiyan Anbazhagan
- Division of Bacteriology and Mycology, ICAR-Indian Veterinary Research Institute, Izatnagar, India
| | - Kumaragurubaran Karthik
- Central University Laboratory, Tamil Nadu Veterinary and Animal Sciences University, Chennai, India
| | - Madesh Angappan
- Division of Public Health and Epidemiology, ICAR-Indian Veterinary Research Institute, Izatnagar, India
| | - Balusamy Dhayananth
- Division of Public Health and Epidemiology, ICAR-Indian Veterinary Research Institute, Izatnagar, India
| |
Collapse
|
7
|
De Puysseleyr L, De Puysseleyr K, Rybarczyk J, Vander Donck P, De Vos WH, Vanrompay D. Transferrins Reduce Replication of Chlamydia suis in McCoy Cells. Pathogens 2021; 10:pathogens10070858. [PMID: 34358007 PMCID: PMC8308531 DOI: 10.3390/pathogens10070858] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2021] [Revised: 07/02/2021] [Accepted: 07/04/2021] [Indexed: 11/25/2022] Open
Abstract
Chlamydia suis (C. suis) resides in the intestines of pigs and tetracycline-resistant strains are emerging worldwide. Intestinal infections are often subclinical. However, the gut is regarded as a C. suis reservoir and clinical infections have been associated with enteritis, conjunctivitis, pneumonia and reproductive failure. C. suis was found in boar semen and venereal transmission occurred. We studied the anti-Chlamydia suis activity of ovotransferrin (ovoTF) and bovine lactoferrin (bLF). Pre-incubation of C. suis with bLF or ovoTF had no significant effect on overall chlamydia replication (mean fluorescence area) in McCoy cells. The addition of ovoTF to the culture medium had no effect on bacterial replication, but the addition of 0.5 or 5 mg/mL of bLF significantly reduced the inclusion size by 17% and 15% respectively. Egg components are used for cryopreservation of boar semen. When inoculating an ovoTF-containing and Chlamydia suis-spiked semen sample in McCoy cells, a significant reduction in inclusion number (by 7%) and overall replication (by 11%) was observed. Thus, we showed that transferrins possess anti-chlamydial activity. Moreover, ovoTF addition to semen extenders might reduce C. suis venereal transmission. Further research is needed to unravel the mechanisms behind the observations and to enhance the effect of transferrins on C. suis.
Collapse
Affiliation(s)
- Leentje De Puysseleyr
- Laboratory for Immunology and Animal Biotechnology, Faculty of Bioscience Engineering, Ghent University, 9000 Ghent, Belgium; (L.D.P.); (K.D.P.); (J.R.); (P.V.D.)
| | - Kristien De Puysseleyr
- Laboratory for Immunology and Animal Biotechnology, Faculty of Bioscience Engineering, Ghent University, 9000 Ghent, Belgium; (L.D.P.); (K.D.P.); (J.R.); (P.V.D.)
| | - Joanna Rybarczyk
- Laboratory for Immunology and Animal Biotechnology, Faculty of Bioscience Engineering, Ghent University, 9000 Ghent, Belgium; (L.D.P.); (K.D.P.); (J.R.); (P.V.D.)
| | - Paulien Vander Donck
- Laboratory for Immunology and Animal Biotechnology, Faculty of Bioscience Engineering, Ghent University, 9000 Ghent, Belgium; (L.D.P.); (K.D.P.); (J.R.); (P.V.D.)
| | - Winnok H. De Vos
- Laboratory of Cell Biology and Histology, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, 2610 Wilrijk, Belgium;
| | - Daisy Vanrompay
- Laboratory for Immunology and Animal Biotechnology, Faculty of Bioscience Engineering, Ghent University, 9000 Ghent, Belgium; (L.D.P.); (K.D.P.); (J.R.); (P.V.D.)
- Correspondence:
| |
Collapse
|
8
|
Marti H, Bommana S, Read TD, Pesch T, Prähauser B, Dean D, Borel N. Generation of Tetracycline and Rifamycin Resistant Chlamydia Suis Recombinants. Front Microbiol 2021; 12:630293. [PMID: 34276577 PMCID: PMC8278220 DOI: 10.3389/fmicb.2021.630293] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Accepted: 06/03/2021] [Indexed: 01/01/2023] Open
Abstract
The Chlamydiaceae are a family of obligate intracellular, gram-negative bacteria known to readily exchange DNA by homologous recombination upon co-culture in vitro, allowing the transfer of antibiotic resistance residing on the chlamydial chromosome. Among all the obligate intracellular bacteria, only Chlamydia (C.) suis naturally integrated a tetracycline resistance gene into its chromosome. Therefore, in order to further investigate the readiness of Chlamydia to exchange DNA and especially antibiotic resistance, C. suis is an excellent model to advance existing co-culture protocols allowing the identification of factors crucial to promote homologous recombination in vitro. With this strategy, we co-cultured tetracycline-resistant with rifamycin group-resistant C. suis, which resulted in an allover recombination efficiency of 28%. We found that simultaneous selection is crucial to increase the number of recombinants, that sub-inhibitory concentrations of tetracycline inhibit rather than promote the selection of double-resistant recombinants, and identified a recombination-deficient C. suis field isolate, strain SWA-110 (1-28b). While tetracycline resistance was detected in field isolates, rifampicin/rifamycin resistance (RifR) had to be induced in vitro. Here, we describe the protocol with which RifR C. suis strains were generated and confirmed. Subsequent whole-genome sequencing then revealed that G530E and D461A mutations in rpoB, a gene encoding for the β-subunit of the bacterial RNA polymerase (RNAP), was likely responsible for rifampicin and rifamycin resistance, respectively. Finally, whole-genome sequencing of recombinants obtained by co-culture revealed that recombinants picked from the same plate may be sibling clones and confirmed C. suis genome plasticity by revealing variable, apparently non-specific areas of recombination.
Collapse
Affiliation(s)
- Hanna Marti
- Vetsuisse Faculty, Institute of Veterinary Pathology, University of Zurich, Zurich, Switzerland
| | - Sankhya Bommana
- Division of Infectious Diseases, Departments of Medicine and Pediatrics, University of California San Francisco School of Medicine, San Francisco, CA, United States
| | - Timothy D Read
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.,Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, United States
| | - Theresa Pesch
- Vetsuisse Faculty, Institute of Veterinary Pathology, University of Zurich, Zurich, Switzerland
| | - Barbara Prähauser
- Vetsuisse Faculty, Institute of Veterinary Pathology, University of Zurich, Zurich, Switzerland
| | - Deborah Dean
- Division of Infectious Diseases, Departments of Medicine and Pediatrics, University of California San Francisco School of Medicine, San Francisco, CA, United States.,Joint Graduate Program in Bioengineering, University of California, San Francisco, San Francisco, CA, United States.,Joint Graduate Program in Bioengineering, University of California, Berkeley, Berkeley, CA, United States
| | - Nicole Borel
- Vetsuisse Faculty, Institute of Veterinary Pathology, University of Zurich, Zurich, Switzerland
| |
Collapse
|
9
|
Rohner L, Marti H, Torgerson P, Hoffmann K, Jelocnik M, Borel N. Prevalence and molecular characterization of C. pecorum detected in Swiss fattening pigs. Vet Microbiol 2021; 256:109062. [PMID: 33848714 DOI: 10.1016/j.vetmic.2021.109062] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2021] [Accepted: 03/24/2021] [Indexed: 11/25/2022]
Abstract
Chlamydia (C.) pecorum, an obligate intracellular bacterial species commonly found in ruminants, can also occur in pigs. However, its significance as a potential porcine pathogen, or commensal, is still unclear. In a previous study (Hoffmann et al. 2015), mixed infections of C. suis and C. pecorum were detected in 14 Swiss fattening pig farms. Using these samples, we aimed to investigate the infection dynamics of C. suis and C. pecorum mixed infections in these farms. In addition, we analyzed the genetic diversity of Swiss porcine C. pecorum strains in relation to globally circulating strains. In total, 1284 conjunctival and rectal swabs from 391 pigs, collected at the beginning and end of the fattening period, were tested during the course of this study. We determined the bacterial loads of C. suis and C. pecorum using species-specific real-time PCR (qPCR) and compared these results to already existing DNA-microarray and Chlamydiaceae qPCR data. Overall, C. suis and Chlamydiaceae copy numbers decreased in the course of the fattening period, whereas C. pecorum copy numbers increased. No association was found between clinical signs (conjunctivitis, lameness and diarrhea) and the bacterial loads. Preventive antibiotic treatment at the beginning of the fattening period significantly lowered the chlamydial load and outdoor access was associated with higher loads. Proximity to the nearest ruminants correlated with increased C. pecorum loads, indicating that C. pecorum could be transmitted from ruminants to pigs. Multi-locus sequence typing (MLST) and major outer membrane protein (ompA) genotyping revealed two novel sequence types (STs) (301, 302) and seven unique ompA genotypes (1-7) that appear to form a specific clade separate from other European C. pecorum strains.
Collapse
Affiliation(s)
- Lea Rohner
- Institute of Veterinary Pathology, Vetsuisse-Faculty University Zurich, Zurich, 8057, Switzerland; Center for Clinical Studies, Vetsuisse-Faculty, University of Zurich, Zurich, 8057, Switzerland
| | - Hanna Marti
- Institute of Veterinary Pathology, Vetsuisse-Faculty University Zurich, Zurich, 8057, Switzerland; Center for Clinical Studies, Vetsuisse-Faculty, University of Zurich, Zurich, 8057, Switzerland.
| | - Paul Torgerson
- Section of Veterinary Epidemiology, Vetsuisse-Faculty, University of Zurich, Zurich, 8057, Switzerland
| | - Karolin Hoffmann
- Institute of Veterinary Pathology, Vetsuisse-Faculty University Zurich, Zurich, 8057, Switzerland; Center for Clinical Studies, Vetsuisse-Faculty, University of Zurich, Zurich, 8057, Switzerland
| | - Martina Jelocnik
- Genecology Research Centre, University of the Sunshine Coast, Sippy Downs, 4556, Queensland, Australia
| | - Nicole Borel
- Institute of Veterinary Pathology, Vetsuisse-Faculty University Zurich, Zurich, 8057, Switzerland; Center for Clinical Studies, Vetsuisse-Faculty, University of Zurich, Zurich, 8057, Switzerland
| |
Collapse
|
10
|
Hoque MM, Adekanmbi F, Barua S, Rahman KS, Aida V, Anderson B, Poudel A, Kalalah A, Bolds S, Madere S, Kitchens S, Price S, Brown V, Lockaby BG, Kyriakis CS, Kaltenboeck B, Wang C. Peptide ELISA and FRET-qPCR Identified a Significantly Higher Prevalence of Chlamydia suis in Domestic Pigs Than in Feral Swine from the State of Alabama, USA. Pathogens 2020; 10:pathogens10010011. [PMID: 33375583 PMCID: PMC7823902 DOI: 10.3390/pathogens10010011] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2020] [Revised: 12/20/2020] [Accepted: 12/22/2020] [Indexed: 12/25/2022] Open
Abstract
Chlamydia suis is an important, highly prevalent, and diverse obligate intracellular pathogen infecting pigs. In order to investigate the prevalence and diversity of C. suis in the U.S., 276 whole blood samples from feral swine were collected as well as 109 fecal swabs and 60 whole blood samples from domestic pigs. C. suis-specific peptide ELISA identified anti-C. suis antibodies in 13.0% of the blood of feral swine (26/276) and 80.0% of the domestic pigs (48/60). FRET-qPCR and DNA sequencing found C. suis DNA in 99.1% of the fecal swabs (108/109) and 21.7% of the whole blood (13/60) of the domestic pigs, but not in any of the assayed blood samples (0/267) in feral swine. Phylogenetic comparison of partial C. suis ompA gene sequences and C. suis-specific multilocus sequencing typing (MLST) revealed significant genetic diversity of the C. suis identified in this study. Highly genetically diverse C. suis strains are prevalent in domestic pigs in the USA. As crowding strongly enhances the frequency and intensity of highly prevalent Chlamydia infections in animals, less population density in feral swine than in domestic pigs may explain the significantly lower C. suis prevalence in feral swine. A future study is warranted to obtain C. suis DNA from feral swine to perform genetic diversity of C. suis between commercial and feral pigs.
Collapse
Affiliation(s)
- Md Monirul Hoque
- College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA; (M.M.H.); (F.A.); (S.B.); (K.S.R.); (V.A.); (A.P.); (A.K.); (S.K.); (S.P.); (C.S.K.); (B.K.)
| | - Folasade Adekanmbi
- College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA; (M.M.H.); (F.A.); (S.B.); (K.S.R.); (V.A.); (A.P.); (A.K.); (S.K.); (S.P.); (C.S.K.); (B.K.)
| | - Subarna Barua
- College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA; (M.M.H.); (F.A.); (S.B.); (K.S.R.); (V.A.); (A.P.); (A.K.); (S.K.); (S.P.); (C.S.K.); (B.K.)
| | - Kh. Shamsur Rahman
- College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA; (M.M.H.); (F.A.); (S.B.); (K.S.R.); (V.A.); (A.P.); (A.K.); (S.K.); (S.P.); (C.S.K.); (B.K.)
| | - Virginia Aida
- College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA; (M.M.H.); (F.A.); (S.B.); (K.S.R.); (V.A.); (A.P.); (A.K.); (S.K.); (S.P.); (C.S.K.); (B.K.)
| | - Brian Anderson
- Swine Research and Education Center, Auburn University, Auburn, AL 36830, USA;
| | - Anil Poudel
- College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA; (M.M.H.); (F.A.); (S.B.); (K.S.R.); (V.A.); (A.P.); (A.K.); (S.K.); (S.P.); (C.S.K.); (B.K.)
| | - Anwar Kalalah
- College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA; (M.M.H.); (F.A.); (S.B.); (K.S.R.); (V.A.); (A.P.); (A.K.); (S.K.); (S.P.); (C.S.K.); (B.K.)
| | - Sara Bolds
- School of Forestry and Wildlife Sciences, Auburn University, Auburn, AL 36849, USA; (S.B.); (S.M.); (B.G.L.)
| | - Steven Madere
- School of Forestry and Wildlife Sciences, Auburn University, Auburn, AL 36849, USA; (S.B.); (S.M.); (B.G.L.)
| | - Steven Kitchens
- College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA; (M.M.H.); (F.A.); (S.B.); (K.S.R.); (V.A.); (A.P.); (A.K.); (S.K.); (S.P.); (C.S.K.); (B.K.)
| | - Stuart Price
- College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA; (M.M.H.); (F.A.); (S.B.); (K.S.R.); (V.A.); (A.P.); (A.K.); (S.K.); (S.P.); (C.S.K.); (B.K.)
| | - Vienna Brown
- National Feral Swine Damage Management Program, Wildlife Services, Animal and Plant Health Inspection Service, United States Department of Agriculture, Fort Collins, CO 80521, USA;
| | - B. Graeme Lockaby
- School of Forestry and Wildlife Sciences, Auburn University, Auburn, AL 36849, USA; (S.B.); (S.M.); (B.G.L.)
| | - Constantinos S. Kyriakis
- College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA; (M.M.H.); (F.A.); (S.B.); (K.S.R.); (V.A.); (A.P.); (A.K.); (S.K.); (S.P.); (C.S.K.); (B.K.)
| | - Bernhard Kaltenboeck
- College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA; (M.M.H.); (F.A.); (S.B.); (K.S.R.); (V.A.); (A.P.); (A.K.); (S.K.); (S.P.); (C.S.K.); (B.K.)
| | - Chengming Wang
- College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA; (M.M.H.); (F.A.); (S.B.); (K.S.R.); (V.A.); (A.P.); (A.K.); (S.K.); (S.P.); (C.S.K.); (B.K.)
- Correspondence:
| |
Collapse
|